Assignee
POLYPHOR AG
CH·24 granted patents·6 pending applications·43 citations·filing 2005–2023
Top patents by PatentIndex Score
30 records- 0190US7091313B2Synthesis of template-fixed β-hairpin loop mimeticsPOLYPHOR AG·Filed 2005·Granted Aug 15, 2006·13 cites·12 claims
- 0288US11235023B2Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereofPOLYPHOR AG·Filed 2017·Granted Feb 1, 2022·2 cites·14 claims
- 0384US9556231B2Beta-hairpin peptidomimetics as CXC4 antagonistsPOLYPHOR AG·Filed 2015·Granted Jan 31, 2017·4 cites·11 claims
- 0481US9284352B2Beta-hairpin peptidomimetics having CXCR4 antagonizing activityPOLYPHOR AG·Filed 2014·Granted Mar 15, 2016·4 cites·4 claims
- 0578US10829520B2Beta-hairpin peptidomimeticsPOLYPHOR AG·Filed 2016·Granted Nov 10, 2020·3 cites·10 claims
- 0678US9637520B2Template-fixed peptidomimetics with CXCR7 modulating activityPOLYPHOR AG·Filed 2015·Granted May 2, 2017·3 cites·10 claims
- 0777US9938322B2β-hairpin peptidomimeticsPOLYPHOR AG·Filed 2014·Granted Apr 10, 2018·2 cites·14 claims
- 0876US9814754B2Combinations with a backbone-cyclized peptidePOLYPHOR AG·Filed 2013·Granted Nov 14, 2017·3 cites·24 claims
- 0976US9775877B2Combinations with a backbone-cyclized peptidePOLYPHOR AG·Filed 2013·Granted Oct 3, 2017·3 cites·10 claims
- 1075US10370411B2Beta-hairpin peptidomimeticsPOLYPHOR AG·Filed 2017·Granted Aug 6, 2019·1 cites·18 claims
- 1174US10017481B2Conformationally constrained, fully synthetic macrocyclic compoundsPOLYPHOR AG·Filed 2013·Granted Jul 10, 2018·5 cites·15 claims
- 1272US2023381270A1Pharmaceutical combinations for treating cancerPOLYPHOR AG·Filed 2023·Application pending·0 cites
- 1369US11844823B2Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereofPOLYPHOR AG·Filed 2021·Granted Dec 19, 2023·0 cites·32 claims
- 1460US11235024B2Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereofPOLYPHOR AG·Filed 2017·Granted Feb 1, 2022·0 cites·6 claims
- 1558US2021187059A1Pharmaceutical combinations for treating cancerPOLYPHOR AG·Filed 2018·Application pending·0 cites
- 1658US2024009266A1Pharmaceutical combinations comprising a peptide cxcr4 inhibitor and a taxane for treating cancerPOLYPHOR AG·Filed 2021·Application pending·0 cites
- 1758US2020317735A1Beta-hairpin peptidomimetics as selective elastase inhibitorsPOLYPHOR AG·Filed 2020·Application pending·0 cites
- 1857US11753446B2Beta-hairpin peptidomimeticsPOLYPHOR AG·Filed 2020·Granted Sep 12, 2023·0 cites·2 claims
- 1956US10723765B2Beta-hairpin peptidomimetics as selective elastase inhibitorsPOLYPHOR AG·Filed 2013·Granted Jul 28, 2020·0 cites·5 claims
- 2056US2011230426A1Template-fixed peptidomimeticsPOLYPHOR AG·Filed 2008·Application pending·0 cites
- 2155US9850284B2Beta-hairpin peptidomimeticsPOLYPHOR AG·Filed 2014·Granted Dec 26, 2017·0 cites·12 claims
- 2252US10654897B2β-hairpin peptidomimeticsPOLYPHOR AG·Filed 2015·Granted May 19, 2020·0 cites·10 claims
- 2348US10370412B2Beta-hairpin peptidomimeticsPOLYPHOR AG·Filed 2017·Granted Aug 6, 2019·0 cites·18 claims
- 2448US10363284B2β-hairpin peptidomimeticsPOLYPHOR AG·Filed 2017·Granted Jul 30, 2019·0 cites·12 claims
- 2546US2017369523A1Template-fixed beta-hairpin peptidomimetics that are ligands for g-protein-coupled receptors (gpcrs) and are modulators of transcription factors and coactivatorsPOLYPHOR AG·Filed 2017·Application pending·0 cites
- 2640US10273267B2Beta-hairpin peptidomimetics as selective elastase inhibitorsPOLYPHOR AG·Filed 2013·Granted Apr 30, 2019·0 cites·12 claims
- 2740US9957297B2Template-fixed peptidomimetics as inhibitors of FPR1POLYPHOR AG·Filed 2012·Granted May 1, 2018·0 cites·12 claims
- 2834US10730911B2Backbone-cyclized peptidomimetics with GLP-1R modulating activityPOLYPHOR AG·Filed 2016·Granted Aug 4, 2020·0 cites·15 claims
- 2933US11629171B2Beta-hairpin peptidomimeticsPOLYPHOR AG·Filed 2018·Granted Apr 18, 2023·0 cites·3 claims
- 3032US10259847B2Beta-hairpin peptidomimeticsPOLYPHOR AG·Filed 2015·Granted Apr 16, 2019·0 cites·11 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →